Literature DB >> 28670086

Posterior reversible leukoencephalopathy syndrome after kratom ingestion.

Austin Castillo1, J Drew Payne1, Kenneth Nugent1.   

Abstract

Posterior reversible encephalopathy syndrome has been associated with hypertension, preeclampsia, cancer chemotherapy, and drugs of abuse, such as amphetamine and methamphetamine. We report a young man who suddenly developed severe headache, disorientation, and aphasia following ingestion of kratom and Adderall. Computed tomography and magnetic resonance imaging of his head revealed foci of vasogenic edema in the posterior occipital lobes, frontal lobes, and brainstem. In addition, he had a small area of hemorrhage in the left posterior occipital lobe. Lumbar puncture revealed an increased number of red blood cells but no other abnormalities. His initial blood pressure was elevated but returned to normal during hospitalization. This case suggests that kratom can cause posterior reversible encephalopathy syndrome and needs to be considered when patients present to emergency centers with headaches, confusion, and visual disturbances.

Entities:  

Year:  2017        PMID: 28670086      PMCID: PMC5468044          DOI: 10.1080/08998280.2017.11929647

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Posterior reversible encephalopathy syndrome after combined general and spinal anesthesia with intrathecal morphine.

Authors:  Ayelet Eran; Michal Barak
Journal:  Anesth Analg       Date:  2009-02       Impact factor: 5.108

Review 2.  The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Authors:  Marcus L Warner; Nellie C Kaufman; Oliver Grundmann
Journal:  Int J Legal Med       Date:  2015-10-28       Impact factor: 2.686

Review 3.  Neurobiology of Kratom and its main alkaloid mitragynine.

Authors:  Farah W Suhaimi; Nurul H M Yusoff; Rahimah Hassan; Sharif M Mansor; Visweswaran Navaratnam; Christian P Müller; Zurina Hassan
Journal:  Brain Res Bull       Date:  2016-03-25       Impact factor: 4.077

4.  Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases.

Authors:  R B Schwartz; K M Jones; P Kalina; R L Bajakian; M T Mantello; B Garada; B L Holman
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

5.  Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure.

Authors:  Jamie L Nelsen; Jeff Lapoint; Michael J Hodgman; Kenneth M Aldous
Journal:  J Med Toxicol       Date:  2010-12

6.  Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.

Authors:  Mehruba Anwar; Royal Law; Josh Schier
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-07-29       Impact factor: 17.586

Review 7.  A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder.

Authors:  Leslie Briars; Timothy Todd
Journal:  J Pediatr Pharmacol Ther       Date:  2016 May-Jun

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

  9 in total
  9 in total

1.  The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids.

Authors:  Laura Flores-Bocanegra; Huzefa A Raja; Tyler N Graf; Mario Augustinović; E Diane Wallace; Shabnam Hematian; Joshua J Kellogg; Daniel A Todd; Nadja B Cech; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2020-06-29       Impact factor: 4.050

2.  Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.

Authors:  Rhome L Hughes
Journal:  Forensic Sci Med Pathol       Date:  2018-11-29       Impact factor: 2.007

3.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

Review 4.  Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review.

Authors:  Catherine W Striley; Carolin C Hoeflich; Andrew T Viegas; Lindsey A Berkowitz; Emily G Matthews; Leyla P Akin; Chidinma Iheanyi-Okeahialam; Urmeen Mansoor; Christopher R McCurdy
Journal:  Subst Abuse       Date:  2022-05-20

5.  A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES).

Authors:  Haider Ghazanfar; Aruna Muthumanickam; Zaheer Qureshi; Faryal Altaf; Cosmina Zeana; Sridhar Chilimuri
Journal:  Am J Case Rep       Date:  2022-04-26

6.  Recurrent seizures from chronic kratom use, an atypical herbal opioid.

Authors:  William O Tatum; Tasneem F Hasan; Erin E Coonan; Christopher P Smelick
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-17

7.  Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study.

Authors:  Antonio Metastasio; Elisabeth Prevete; Darshan Singh; Oliver Grundmann; Walter C Prozialeck; Charles Veltri; Giuseppe Bersani; Ornella Corazza
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

8.  Cerebellar talcosis following posterior reversible encephalopathy syndrome in an intravenous methamphetamine abuser.

Authors:  Nidal Bassam Omar; Gustavo Chagoya; Galal A Elsayed; Silvio H Litovsky; James R Hackney; Winfield S Fisher
Journal:  Surg Neurol Int       Date:  2021-01-05

9.  A case of posterior reversible encephalopathy syndrome during endoscopic retrograde cholangiopancreatography after anesthesia.

Authors:  Amir Sadeghi; Isa Bakhshandeh Moghadam; Azita Hekmatdoost; Niloufar Salehi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.